Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
NASA's make-or-break moon shot - 2Tesla Germany Registrations Quadruple to 9,252 Vehicles in Best March Ever
- 3A soft launch, an unfollow and a lot of questions: Breaking down the 'Summer House' romance blowing up group chats
- 4UK consumer confidence plunges amid escalating Iran conflict
- 5Al-Sharaa denies he called for 80% of Syrians to return from Germany
- Manual for 6 Busssiness Class Flights
- When faith comes under fire: How Iran’s repression of religious minorities has increased
- Florence's Uffizi Gallery moves treasures to safety after cyberattack
- Pocket-Accommodating Jeep Wrangler Buying Guide for Seniors
- How Google, Microsoft, Walmart, and other corporate giants are preparing for an aging workforce
- This Week In Space podcast: Episode 187 — An Inspired Enterprise
- Lockheed Martin opens new hypersonic weapons facility
- The most effective method to Pick the Right Material Organization: Fundamental Tips
- Police investigate Lahav 433 officer accused of sexually harassing subordinate policewoman
